COMPANY
O.N. Diagnostics
NIH awards 15
- NIH award 5R01AR074958-03 FY2022: $584,616 awarded for that fiscal year; activity R01 (OTHER_NIH); PI KOPPERDAHL, DAVID; recipient as written: O. N. DIAGNOSTICS, LLC, BERKELEY, CA. Clinical Biomechanics of Hip Fractu source ↗
- NIH award 5R01AR074958-02 FY2021: $600,162 awarded for that fiscal year; activity R01 (OTHER_NIH); PI KOPPERDAHL, DAVID; recipient as written: O. N. DIAGNOSTICS, LLC, BERKELEY, CA. Clinical Biomechanics of Hip Fractu source ↗
- NIH award 1R01AR074958-01A1 FY2020: $647,058 awarded for that fiscal year; activity R01 (OTHER_NIH); PI KOPPERDAHL, DAVID; recipient as written: O. N. DIAGNOSTICS, LLC, BERKELEY, CA. Clinical Biomechanics of Hip Frac source ↗
- NIH award 5R44AR064613-03 FY2019: $578,277 awarded for that fiscal year; activity R44 (SBIR); PI KOPPERDAHL, DAVID; recipient as written: O. N. DIAGNOSTICS, LLC, BERKELEY, CA. Pre-Operative Assessment of Fusion-Relat source ↗
- NIH award 2R44AR064613-02 FY2018: $814,222 awarded for that fiscal year; activity R44 (SBIR); PI KOPPERDAHL, DAVID; recipient as written: O. N. DIAGNOSTICS, LLC, BERKELEY, CA. Pre-Operative Assessment of Fusion-Relat source ↗
- NIH award 5R44AR057616-05 FY2016: $600,000 awarded for that fiscal year; activity R44 (SBIR); PI KOPPERDAHL, DAVID; recipient as written: O. N. DIAGNOSTICS, LLC, BERKELEY, CA. Robust BCT for Clinical Use - Phase II source ↗
- NIH award 5R44AR057616-04 FY2015: $600,000 awarded for that fiscal year; activity R44 (SBIR); PI KOPPERDAHL, DAVID; recipient as written: O. N. DIAGNOSTICS, LLC, BERKELEY, CA. Robust BCT for Clinical Use - Phase II source ↗
- NIH award 1R43AR064613-01A1 FY2014: $225,000 awarded for that fiscal year; activity R43 (SBIR); PI KOPPERDAHL, DAVID; recipient as written: O. N. DIAGNOSTICS, LLC, BERKELEY, CA. Pre-Operative Assessment of Fusion-Rel source ↗
- NIH award 2R44AR057616-03A1 FY2014: $600,000 awarded for that fiscal year; activity R44 (SBIR); PI KOPPERDAHL, DAVID; recipient as written: O. N. DIAGNOSTICS, LLC, BERKELEY, CA. Robust BCT for Clinical Use - Phase II source ↗
- NIH award 5R43AR057616-02 FY2010: $350,000 awarded for that fiscal year; activity R43 (SBIR); PI KOPPERDAHL, DAVID; recipient as written: O. N. DIAGNOSTICS, LLC, BERKELEY, CA. Robust BCT for Clinical Use source ↗
- NIH award 5R44AR052234-03 FY2010: $343,961 awarded for that fiscal year; activity R44 (SBIR); PI KOPPERDAHL, DAVID; recipient as written: O. N. DIAGNOSTICS, LLC, BERKELEY, CA. Clinical Validation of BCT - Phase II source ↗
- NIH award 3R44AR052234-02A1S1 FY2010: $194,177 awarded for that fiscal year; activity R44 (SBIR); PI KOPPERDAHL, DAVID; recipient as written: O. N. DIAGNOSTICS, LLC, BERKELEY, CA. Clinical Validation of BCT - Phase I source ↗
- NIH award 2R44AR052234-02A1 FY2009: $220,056 awarded for that fiscal year; activity R44 (SBIR); PI KOPPERDAHL, DAVID; recipient as written: O. N. DIAGNOSTICS, LLC, BERKELEY, CA. Clinical Validation of BCT - Phase II source ↗
- NIH award 1R43AR057616-01 FY2009: $350,000 awarded for that fiscal year; activity R43 (SBIR); PI KOPPERDAHL, DAVID; recipient as written: O. N. DIAGNOSTICS, LLC, BERKELEY, CA. Robust BCT for Clinical Use source ↗
- NIH award 1R43AR052234-01A2 FY2007: $102,320 awarded for that fiscal year; activity R43 (SBIR); PI KOPPERDAHL, DAVID; recipient as written: O. N. DIAGNOSTICS, LLC, BERKELEY, CA. Clinical Validation of BCT source ↗